Associate Professor

Research Interests
Research Summary

Research Interests

  • The development and demonstration of clinical efficacy of low molecular weight heparin fractions
  • Investigation of a new antithrombin-III variant with discrepant functional to immuno ATIII levels
  • Development of laboratory markers to detect hypercoagulable states
  • Diagnostic application of platelet activation dependent antibodies
Bio

FRCP(London), Internal Medicine, 1981
FRCP(C), Haematology, 1976
FRCP(C), Internal Medicine, 1976
Senior Research Fellow, Ontario Heart Foundation, McMaster, 1985
Research Fellow, Ontario Heart Foundation, McMaster, 1980
B.S., St. Thomas Hospital Medical School, 1969
M.B., University of London, 1969

Publications
  1. Carter ISR, Hewitt J, Pu CH, Wu JK, Carter CJ, MacGillivray RTA. Severe protein S deficiency resulting from two novel mutations in PROS1 presenting with a relatively mild clinical phenotype. J Thromb Haemost 2008; 6:1237-1239
  2. Maurer-Spurej E, Kahr W, Carter CJ, Pittendreigh C, Cameron M, Cyr T. The value of proteomics for the diagnosis of a platelet-related bleeding disorder. Platelets. 2008 19(5):342-351
  3. Zhang JG, Carter CJ, Culibrk B, Devine DV, Levin E, Scammell K, Weiss S, Gyongyossy-Issa MI. Buffycoat platelet variables and metabolism during storage in additive solutions or plasma. Transfusion. 2008Feb 21; [Epub ahead of print]
  4. Zhang JG, Carter CJ, Devine DV, Scammell K, Weiss S, Gyongyossy-Issa MI. Comparison of a novel viscous platelet additive solution and plasma: preparation and in vitro storage parameters of buffy-coat-derived platelet concentrates. Vox Sang. 2008 Jan 4; [Epub ahead of print]
  5. Sunderji R, Gin K, Shalansky K, Carter C, Chambers K, Davies C, Schwartz L, Fung A. Clinical impact of point-of-care vs laboratory measurement of anticoagulation. Am J Clin Pathol. 2005 Feb;123(2):184-8.
  6. Sunderji R, Gin K, Shalansky K, Carter C, Chambers K, Davies C, Schwartz L, Fung A. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Can J Cardiol. 2004 Sep;20(11):1117-23.
  7. Gyongyossy-Issa M, Bussel JB, Carter CJ, Devine DV. Comparison of thrombopoiesis during ITP and HIVITP and response to intravenous gammaglobulin treatment. Platelets 14(5), Aug 2003; 267-27.
  8. Sunderji R, Fung A, Gin K, Shalansky K, Carter C. Patient self-management of oral anticoagulation: a review. Can J Cardiol. 2003 Jul;19(8):931-5.
  9. Verma AK, Levine M, Shalansky SJ, Carter CJ, Kelton JG. Frequency of heparin-induced thrombocytopenia in critical care patients. Pharmacotherapy. 2003 Jun;23(6):745-53.
  10. Nimmo MC, Carter CJ. The antiphospholipid antibody syndrome, a riddle wrrapped in a mystery inside an enigma. Clin Appl Immunol Rev 2003; 4:125-140.
  11. Lee DH, Walker IR, Teitel J, Poon MC, Ritchie B, Akabutu J, Sinclair GD, Pai M, Wu JW, Reddy S, Carter C, Growe G, Lillicrap D, Lam M, Blajchman MA. Effect of the factor V Leiden mutation on the clinicalexpression of severe hemophilia A. Thromb Haemost. 2000 Mar;83(3):387-91.
  12. Janzen J, Elliott TG, Carter CJ, Brooks DE. Detection of red cell aggregation by low shear rate viscometry in whole blood with elevated plasma viscosity. Biorheology. 2000;37(3):225-37.
  13. Carter CJ, Serrano K, Breen DJ, Buckley AR, Devine DV. Rapid fibrin D-dimer tests for deep venous thrombosis: factors affecting diagnostic utility. J Emerg Med. 1999 Jul-Aug;17(4):605-10.
  14. Sunderji R, Campbell L, Shalansky K, Fung A, Carter C, Gin K. Outpatient self-management of warfarin therapy: a pilot study. Pharmacotherapy. 1999 Jun;19(6):787-93.
  15. Leech BF, Carter CJ. Falsely elevated INR results due to the sensitivity of a thromboplastin reagent to heparin. Am J Clin Pathol. 1998 Jun;109(6):764-8.
  16. Freeman HJ, Roeck B, Devine DV, Carter CJ. Atypical perinuclear antineutrophil cytoplasmic antibodies after colectomy in inflammatory bowel disease. Can J Gastroenterol. 1997 May-Jun;11(4):305-10.
  17. Freeman H, Roeck B, Devine D, Carter C. Prospective evaluation of neutrophil autoantibodies in 500 consecutive patients with inflammatory bowel disease. Can J Gastroenterol. 1997 Apr;11(3):203-7.
  18. Carter CJ. New developments in acute anticoagulation therapy. Postgraduate Medicine 99(6):129-136 (1996).
  19. Carter CJ. Ferritin levels and iron deficiency. Transfusion. 1994 May;34(5):452-3.
  20. Pi DW, Krikler SH, Sparling TG, Carter CJ, Wadsworth LD. Reappraisal of optimal hemoglobin standards for female blood donors in Canada. Transfusion. 1994 Jan;34(1):7-10.
Office Phone
6048227275
Office
4367